Detalles de la búsqueda
1.
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315).
Int J Cancer;
154(11): 1967-1978, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329180
2.
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
Eur Respir J;
61(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180086
3.
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
JTO Clin Res Rep;
5(4): 100626, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38586301
4.
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Lung Cancer;
152: 174-184, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358484
5.
KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Lung Cancer;
154: 51-61, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33611226
6.
Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174-184].
Lung Cancer;
157: 167, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34049721
Resultados
1 -
6
de 6
1
Próxima >
>>